A Randomized Controlled Study of High-dose Cyclophosphamide Induction Therapy in Adult Patients With HLH

NARecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

April 20, 2023

Primary Completion Date

April 20, 2026

Study Completion Date

May 20, 2027

Conditions
Hemophagocytic Syndrome
Interventions
DRUG

Cytoxan

Cytoxan 40mg/kg iv qd x 2days (day 1 and 2);

DRUG

Etoposide

etoposide(VP16):150 mg/m2, twice a week, 1-2 weeks; 150mg/m2, once a week for the 3rd to 6th week.

DRUG

Dexamethasone

Dexamethasone: 10 mg/m2/day, week 1 to 2; 5 mg/m2/d for the 3rd to 4th week; 2.5 mg/m2/ day at week 5-6.

DRUG

Cyclosporine (CSA)

Cyclosporine (CSA) 100mg Bid, week 1 to 6 (dosed according to 2004 version).

Trial Locations (1)

Unknown

RECRUITING

The Second affiliated Hosptial of Chongqing medical University, Chongqing

All Listed Sponsors
lead

shifeng Lou

OTHER